OXOlife
Developer of a reproductive drug designed to enhance female fertility. The company's drug acts directly on the endometrium to enhance embryo implantation and restore ovulation, enabling clinicians to enhance female fertility success.
1
Funding Rounds
$121.6k
Money raised
Funding series
Funding Series Analysis
The company OXOlife has raised a total of $121.56k in funding over 1 rounds.
Key Insights:
- OXOlife Venture round, January 28, 2021: $121.56k
OXOlife Venture round, January 28, 2021
$121.56k
Industries
OXOlife is active in the following industries: